D-1013-2019 Class II Terminated

Recalled by Mylan Institutional, Inc. (d.b.a. UDL Laboratories) — Rockford, IL

Recall Details

Product Type
Drugs
Report Date
March 27, 2019
Initiation Date
January 18, 2019
Termination Date
April 29, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10,281 UD cartons

Product Description

Alprazolam Tablets, USP, 0.25 mg, 10x10 per carton, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA. NDC: 51079-788-20

Reason for Recall

Failed Impurities/Degradation Specifications: Elevated levels of a known impurity detected during 6-month RT stability interval.

Distribution Pattern

Nationwide USA and Puerto Rico

Code Information

Lots: 3095198, 3096266, 3098776, EXP 05-2019